OSD
Recipharm Analytical Solutions™
Through Recipharm Analytical Solutions™, we support customers with a range of stand-alone analytical requirements.
Our 160-strong analytical development team develops 100s of analytical methods every year. With this expertise, they can support you in the development of formulations ranging from powder in capsules and IV solutions to extended release tablets and dry powder inhalers.
We have a number of state-of-the-art laboratories and stability chambers, which allows us to carry out more than 250 concurrent ongoing stability studies.
The size and flexibility of our labs means we can deliver the results you need rapidly, with minimal delay, helping you overcome development challenges and cutting your time-to-market.
Offering pharma companies access to expert solutions in
- Analytical method development
- Analytical method validation
- Stability programme design and analysis
- Pharmacopeial testing and verification
- Upgrading of outdated methods
- Extractables and leachables (E&L)
Our QbD approach and complex project management skills guarantee high quality, robust and transferable methods.
We have global presence, the capability and scale to take on analytical projects on behalf of customers across the world, freeing up your QC and analytical laboratories.
The capacity and flexibility to scale, allowing us to develop methods for a single project or full multiple projects.
A passionate and expert team, with deep understanding of risk mitigation and regulatory compliance.
A quality release service, called EU release, to pharmaceutical companies situated outside of the EU.
Diverse analytic expertise and specialist knowledge, including:
- all dissolution types
- in vitro permeation testing/in vitro release testing methods (IVPT/IVRT)
- extractables and leachables (E&L)
- performance testing of inhalation products
Want to find out more about how we can help you?